1-1 of 1
Jutte Van der Werff ten Bosch, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Anna Maria Testi, MD, Andrea Pession, MD, David Grimwade, PhD FRCPath, Daniela Diverio, PhD, Christine Ragu, PhD, Sarah Elitzur, MD, Alcira Fynn, MD, Henrik Hasle, MD PhD, Jutte Van der Werff ten Bosch, MD PhD, Owen Smith, MD, Brenda Gibson, MD, Franco Locatelli, MD PhD, Gertjan J.L. Kaspers, MD PhD
Journal: Blood
Blood (2015) 126 (23): 563.
https://doi.org/10.1182/blood.V126.23.563.563
Published: 2015